The Oncology Institute, Inc.

TOI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$53-$83$0-$11
Dep. & Amort.$6$6$4$3
Deferred Tax$0-$0-$0-$1
Stock-Based Comp.$0$18$28$25
Change in WC$18$2-$21-$14
Other Non-Cash$2$21-$73-$34
Operating Cash Flow-$27-$36-$62-$33
Investing Activities
PP&E Inv.-$4-$5-$6-$3
Net Acquisitions$0-$4-$9-$9
Inv. Purchases$0-$10-$118$0
Inv. Sales/Matur.$50$81$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$46$63-$132-$12
Financing Activities
Debt Repay.-$0-$0$110-$7
Stock Issued$0$0$0$0
Stock Repurch.$0-$1-$9$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$4-$6-$9$161
Financing Cash Flow-$3-$7$92$154
Forex Effect$0$0$0$0
Net Chg. in Cash$16$19-$101$109
Supplemental Information
Beg. Cash$33$14$115$6
End Cash$50$33$14$115
Free Cash Flow-$30-$41-$67-$36
The Oncology Institute, Inc. (TOI) Financial Statements & Key Stats | AlphaPilot